BLTE Kronos AI forecast
A 30-trading-day price forecast for Belite Bio Inc American Depositary Shares (BLTE) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Belite Bio Inc American Depositary Shares at $154.28 on 2026-12-08, +5.9% from the last close of $145.72 on 2026-10-27. Eight out of ten sampled paths end between $146.39 and $166.97, and 7 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of BLTE
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $146.10 | $139.00 | $150.00 |
| 2026-11-10 | $150.16 | $140.58 | $158.66 |
| 2026-11-17 | $143.67 | $141.32 | $158.74 |
| 2026-11-24 | $147.76 | $140.44 | $162.44 |
| 2026-12-01 | $149.58 | $139.18 | $161.54 |
| 2026-12-08 | $154.28 | $146.39 | $166.97 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for BLTE?
- Kronos AI's median forecast for BLTE is $154.28 in 30 trading days, +5.9% from the last close, with a 10–90% range of $146.39 to $166.97.
- Is the BLTE Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC